中文

The VTR Biomedicine section participated in the 19th CphI China (CphI China 2019) with the leading products

Date:2019-07-05   From:Liu Xiaofang from Norchem
Group photo of the exhibition team

From June 18 to June 20, the 19th CphI China (CphI China 2019) series exhibition sponsored by Informa Markets and China Chamber of Commerce for Import and Export of Medicines and Health Products was held at Shanghai New International Expo Center. The glittering stand of VTR Group (E2A02) located in the Exhibition Hall E2 of the comprehensive exhibition area of pharmaceutical raw materials, has become the focus of attention of the industry, especially of the overseas customers.

At this exhibition, the enterprises subordinate to the VTR bi-pharmaceutical sector-Norchem Group and Lihua Pharma., etc., with their own leading products, participated in CphI China 2019 as a group. The main exhibition products include various kinds of steroid hormone products such as prednisolone series, hydrocortisone series, betamethasone series, dexamethasone series, sex hormones, progesterone, corticosteroids, etc. 
Chairman of VTR Group Mr. Chen Shaomei is making warm communication with the visitors

The group photo of Chairman of VTR Group Mr. Chen Shaomei with the visitors
Chairman of Norchem Mr. Liu Xirong is making warm communication with the visitor

|

On the morning of June 18th, in a clearly visible position at the entrance to the Exhibition Hall E2, the generous, concise, lively and iconic green stand of VTR attracted much attention and enjoyed great popularity! The sales staff of the subsidiaries cooperated with each other, gave full play to the team spirit, answered relevant questions for customers, and received visitors from more than 60 countries and regions in Europe, America, Asia and Africa… The specialized sales team that answered the questions carefully with patience impressed the customers much.

It is understood that the exhibition area of Cphl of this session exceeded 200,000 square meters for the first time, and more than 3,200 domestic and foreign exhibitors participated in the exhibition. More than 70,000 professional buyers and visitors from more than 120 countries and regions are expected to attend the exhibition lasting for three days. In addition to the professional and wonderful exhibition, more than 100 meeting and forum activities will be also held at the same time in three days, for the purpose of providing top quality, professional, open and sharing learning and communication platform for professionals in the pharmaceutical industry at home and abroad, helping Chinese brands go global.
At the booth of VTR enjoying great popularity





With abundant raw materials and stable supply of plant sterols as the starting materials, the enterprises in the bio-pharmaceutical sector subordinate to VTR realize the production of various kinds of steroidal hormones through biological fermentation and chemical synthesis by using innovative industrial processes, and create a competitive advantage in the whole industrial chain through integrating industry resources and technologies, reducing costs and increasing efficiency. With the steady growth of the demand on steroidal hormone products in the world market, Norchem, Lihua Pharma., etc. have been continuously improving the group research and development capacity, creating the modern production process system, and has passed multiple international certification and product registration in European Union, the United States, etc. The competitive series products with high quality with favorable price show the broad market prospects.

Through accumulation and development for many years, the endogenous power of Norchem and Lihua Pharma. to participate in the division of labor and cooperation in the international pharmaceutical industry have become more and more powerful, and the depth and breadth of cooperation are also continuously expanded. As the global competitive steroid hormone pharmaceutical enterprise, the performance of the bio-pharmaceutical sector of VTR has been developed rapidly, and it plays an increasingly important role in the layout of the international API industry.

At present, trade protectionism is becoming increasingly intensified, the global economic and trade environment is facing more uncertain factors, and the international pharmaceutical industry value chain is undergoing profound adjustment. Under the new situation, how to promote the Chinese pharmaceutical industry to be more effectively embedded in the global value chain, actively participate in the reshaping of the global value chain, and realize the new international layout and development of the Chinese pharmaceutical industry is particularly important. In the future, Norchem will continuously adhere to the concept of “joint creation, common innovation, commitment, the win-win situation”, take this event as an opportunity to improve the level of research and development, go hand in hand with Lihua Pharma. and the counterparts in the steroid drug industry, and work together with customers and friends at home and abroad to develop a new international market pattern.

12019期36选7开奖结果
河北快三 开年赚钱 甘肃11选5 手机版大话西游赚钱不 华夏娱乐苹果 用哪个软件写小说赚钱的 皇家彩票首页 35岁女学什么赚钱 排列5 赚钱宝 硬盘座 快3 哪些靠谱在家赚钱方法 贵州11选5 在呼和浩特做什么比较好赚钱 新疆25选7 喜马拉雅 广告赚钱